Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study

PURPOSE: Valproic acid is an anticonvulsant that also inhibits histone deacetylase (HDAC), a property that could worsen pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The clinical significance of this property is unknown. We therefore compared the risk of COPD exac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacoepidemiol Drug Saf
Asıl Yazarlar: Antoniou, Tony, Yao, Zhan, Camacho, Ximena, Mamdani, Muhammad M, Juurlink, David N, Gomes, Tara
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2015
Konular:
Original Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4497617/
https://ncbi.nlm.nih.gov/pubmed/25656984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3761
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller